Friday 6 November 2026 Export BMY’s income statement to Excel — free account

Bristol Myers Squibb Company

BMY Healthcare Drug Manufacturers General

Bristol Myers Squibb Company’s revenue for fiscal 2025 (year ended December 2025) was $48.2 billion, roughly unchanged from fiscal 2024.

Revenue: +6.93%
EPS: −2.02%
Free cash flow: −36.0%
Total debt: −12.5%

Quarter to September 2026, against a year earlier

62.46 0.67 −1.06%

Follow BMY

Alert me

Market cap: $129.0B
P/E: 14.0×
Fwd P/E: 11.9×
Dividend yield: 3.99%
F-score: 8/9
Altman Z: 2.14
Beneish M: −2.69
Dividend safety: 63/100

Overview Business Profile Earnings & Analysis Segments Valuation Filings

Bristol Myers Squibb Company (BMY) P/E ratio

Alert me on P/E ratio

As of 5 November 2026, Bristol Myers Squibb Company (BMY) trades at a P/E ratio of 14.0×. Over the past ten years it has ranged from 0.0× (March 2025) to 259× (September 2018); the current reading is higher than 29% of that period. That is below the Drug Manufacturers General industry median of 26.6× and below the Healthcare sector median of 25.2×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/BMY/pe-ratio" width="100%" height="360" style="border:0" loading="lazy" title="Bristol Myers Squibb Company P/E ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/BMY/metrics/pe-ratio">Bristol Myers Squibb Company (BMY) P/E ratio — stockrow.com</a></p>

Period	P/E ratio	Change
FY2025	15.6×	—
FY2024	0.0×	—
FY2023	13.6×	(43.92%)
FY2022	24.2×	22.51%
FY2021	19.8×	—
FY2020	0.0×	—
FY2019	29.0×	69.31%
FY2018	17.2×	(82.93%)
FY2017	101×	351.40%
FY2016	22.3×	(69.71%)

Period	P/E ratio	Change
Sep 2026	13.8×	8.82%
Jun 2026	12.7×	(25.50%)
Mar 2026	17.0×	9.28%
Dec 2025	15.6×	2.66%
43 more quarters	Free account

Against its own ten years

Low 0.0× High 259×

Ten-year median 18.8×

Current reading's percentile 11

Company	P/E ratio
GILD Gilead Sciences, Inc. compare	n/m
NVO Novo Nordisk A/S compare	9.9×
BMY Bristol Myers Squibb Company	14.0×
GSK GSK PLC Sponsored ADR compare	16.7×
SNY Sanofi compare	23.2×
AZN AstraZeneca PLC compare	26.3×
AMGN Amgen Inc. compare	26.6×
NVS Novartis AG compare	30.9×
PFE Pfizer Inc. compare	42.2×
Drug Manufacturers General industry median	26.6×
Healthcare sector median	25.2×
Market median	17.9×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

Bristol Myers Squibb Company (BMY) P/E ratio

P/E ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/E ratio against peers

What P/E ratio is

More on BMY

P/E ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/E ratio against peers

What P/E ratio is

More on BMY

Stockrow Weekly